View from the Top
Agustin Azcatl
IP and Regulation Leader
Ortiz & Ramírez Abogados
Through an intense knowledge of the health industry, Ortiz & Ramirez Abogados has identified core opportunities for diverse companies of the…
Weekly Roundups
As COVID-19 vaccine developments move forward, so does Mexico on finding access to such cure.
View from the Top
Santiago Fernández
Executive Vice President of Vehicles, P&C and Health
AXA Mexico
The automotive insurance sector has battled with months of lockdowns. What are AXA's strategies to overcome this?
View from the Top
Josué Garza
Director of Business Development and Operations
Insumos para la Salud
IPS guides foreign medical devices companies to properly target the Mexican market. Its regulatory knowledge has been key to its clients’ success.
View from the Top
Francisco Ruiz Galvan
CEO
ASISPET
"We would like to see more private operators to include them as part of our growing portfolio."
View from the Top
Marcos Pascual
Commercial Director
ANAFARMEX
Pharmacies need to ensure a safe environment and diagnosis of a patient, especially in a COVID-19 scenario where patients cannot go to hospitals.
Analysis
Mexico changed the role of pharmacies when, by law, a medical consultation was needed to purchase medicine
View from the Top
Mario Sicilia
Director General
Laboratorio Médico Polanco
Transforming initiatives to action, Laboratorio Médico Polanco has had an active role in fighting the COVID-19 pandemic.
Expert Contributor
Yolanda Aguirre
Life Sciences Executive Doctor of the Litigation Department
Olivares
https://www.linkedin.com/company/olivares/?originalSubdomain=mx
https://www.olivares.mx/
New uses to the concept of innovation open opportunities for industrial applications within the New Mexican IP Law